Although the number of fusions with known reference splice sites present in thyroid cancer samples was lower than observed for lung cancer samples, it is widely accepted that gene fusions have an important role in thyroid cancer, and drugs have been approved that target some of these (e.g., RET and NTRK) [54,55]. Here, RET is linked to lung cancer.